Thermaiscan signs LOI with Mazumdar Shaw Medical Foundation – Technology Business Incubator in India

Houses in Bengaluru, Karnataka, India
Houses in Bengaluru, Karnataka, India

We have more great news. A Letter of Intent (LOI) has been signed between Thermaiscan and Mazumdar Shaw Medical Foundation – Technology Business Incubator (MSMF-TBI) in Bengaluru, India, which is established to provide philanthropy support, medical outreach and translational research. The intention of the LOI is to perform research and clinical validations in their Corporate Hospital-based Startup Incubator.

The LOI is a testament to the power of community in India. We are extremely thankful to India-Sweden Healthcare Innovation Center with Harika Garapati & Dolly Berry, who represents Business Sweden in India. They introduced us to Mukesh Sharma at Menterra Venture Advisors, who then helped us to reach Dr Sherin James and Kiran Vuppala at MSMF – that were positive towards the Thermaiscan Breast Cancer Pre-Screening solution.

This is Mazumdar Shaw Medical Foundation – Technology Business Incubator 

MSMF-TBI has been actively involved in promoting innovations and entrepreneurship across India, by creating an enabling platform for startups and entrepreneurs to build scalable and sustainable ventures. MSMF-TBI has incubated more than 30+ healthcare startups. 

Recently they were selected for Startup India Seed Fund Scheme from the Ministry of Commerce and Industry, Department for Promotion of Industry and Internal Trade to support early stage startups.

The MSMF-Technology Business Incubator is India’s first corporate hospital based start-up incubator created in 2016, with support from the Department of Science and Technology. The “International Centre for Innovation, Technology transfer and Entrepreneurship” was established with the help of DST and in 2019, MSMF was awarded BIRAC – BioNEST status from the Department of BioTechnology. 

MSMF is nested within the Narayana Health City in Bengaluru. Mazumdar Shaw Medical Foundation was established to provide opportunities for Entrepreneurs, Startups, Innovators, Researchers/Scientists, Clinicians and Philanthropists to contribute to shaping the healthcare of the future and making it accessible to marginalized communities in India.

Thermaiscan – Predictive medicine using software innovations

Thermaiscan is a software company within the predictive medicine field, founded in Sweden. Our mission is to solve the problem of late detection of breast cancer development. Early detection saves lives.

Thermaiscan’s innovation is a breast cancer pre-screening solution based on inhouse developed AI, combined with thermal sensors integrated in smartphones. The goal is to support B2B health units – such as mini-clinics, primary care and rural healthcare non-specialists – with the ability to perform breast cancer pre-screening and detect breast abnormalities in early stages. Finding breast cancer early is strongly correlated with better survival chances. Thermaiscan’s approach with a portable, affordable and non-toxic breast cancer pre-screening solution have gained traction and been rewarded in both India and Singapore. 

Our vision is to have the innovation acting as a complement to current screening methods in the hands of first-line healthcare non-specialist workers.

AI will not replace human specialists, Dr’s or healthcare personell. Humans in healthcare who uses AI will replace the ones who dont use – this is our five cents about the future. AI and thermal technology is like the fish in the water, a perfect combination that outperformes human eye analysis of thermal image.

Collaboration with key healthcare actors in India

Breast cancer accounts for 8.2% of total cancer cases in India. The problem is growing and the need for technology tackling this is big. There are many devoted people and organizations working together to solve this problem.

Thermaiscan recently announced a Letter of Intent with MAMTA Health Institute For Mother And Child In India. Read more here.

Business Sweden in India

Business Sweden has helped Swedish companies grow in India for more than 25 years. From their two offices in Bangalore and New Delhi, they also support Swedish companies in neighboring markets such as Bangladesh, Sri Lanka, Pakistan, Bhutan, Nepal and the Maldives. They help companies understand the business culture, plan market entry in relevant segments, and suggest suitable partners, to mention a few of their key services. You can find more information here

India-Sweden Healthcare Innovation Centre

Thermaiscan Breast Cancer Pre-Screening solution was 1 of 14 winners in India-Sweden Innovation Challenge at the end of 2020. The India-Sweden Healthcare Innovation Centre is envisioned to develop an ecosystem of innovation and healthcare delivery stakeholders to collaborate faster in order to address current and future challenges in the healthcare sector in India. The platform enables development and scaling up through frugal innovation for healthcare that is affordable and accessible in line with the objectives of the Government of India.

Thermaiscan has since then received fantastic support from the India-Sweden Healthcare Innovation Centre. The support includes a partnership between India’s premier healthcare institutions AIIMS Delhi, AIIMS Jodhpur and Business Sweden, closely guided by the Ministry of Health (including ICMR) in Sweden and India, along with Knowledge Partner AstraZeneca as well as Technology Partner NASSCOM.

More on Mazumdar Shaw Medical Foundation (MSMF)

The Mazumdar Shaw Medical Foundation is a not-for-profit organization and was established by Dr. Kiran Mazumdar-Shaw in 2013, with the aim of establishing advanced cancer care infrastructure accessible to all, promoting translational research with a focus on India, and provide philanthropic support to cancer patients. The Foundation’s compassionate care unit, Mazumdar Shaw Cancer Outreach Program is committed to helping underprivileged patients. 

The Mazumdar Shaw Medical Foundation compliments the philanthropic vision of Narayana Health providing a community outreach program and translational research center Mazumdar Shaw Center for Translational Research which has been established with the aim of developing scientific breakthroughs resulting in more effective and affordable healthcare for a wide range of human diseases and conditions. The center provides an interface for the integration of engineering, science and medicine in a discovery-centered environment towards the development of new treatment modalities. 

The mission of the Mazumdar Shaw Medical Foundation is to improve the health of the community by setting a standard of excellence in research and community outreach programs. MSMF pushes the boundaries of discovery, transforms healthcare and creates hope for humanity. We will deliver the promise of good health through breakthrough research, treatment innovation, and philanthropy. MSMF employs world-class researchers who develop and test the effectiveness of new cancer therapies. This unique bench-to-bedside approach to cancer research and patient care can only be found in a distinguished center such as MSMF.

Thermaiscan signs LOI with MAMTA Health Institute for Mother and Child in India

We can share the fantastic news that a Letter of Intent (LOI) has been signed between Thermaiscan and MAMTA Health Institute for Mother and Child (MAMTA-HIMC), a leading national-level not-for-profit organisation that works across 20 states in India.


MAMTA-HIMC, is a New Delhi-based not-for-profit organization, working for more than three decades in the areas of health and development for improving the quality of life of the marginalized and vulnerable population in India and in the region. Currently, it is implementing its project directly in 16 states, and in addition it works in collaboration with network partners in other 4 states across the country. It works very closely with community structures at district and state health facilities, both in the public and private sectors.

Thermaiscan is a Swedish software company within the predictive medicine field. Our mission is to solve the problem of late detection of breast cancer development on a global level. Thermaiscan’s innovation is a breast cancer pre-screening solution based on inhouse developed AI, combined with already existing thermal sensors in smartphones. The goal is to enhance B2B health units – such as mini-clinics, primary care and rural healthcare non-specialists – with the ability to perform breast cancer pre-screening and detect breast abnormalities in early stages. Finding breast cancer early is strongly correlated with better survival chances[1]. Thermaiscan’s approach with a portable, affordable and non-toxic breast cancer pre-screening solution with cutting edge technology has caught interest & been rewarded in India and Singapore. The vision is to have it acting as a complement to current screening methods in the hands of first-line healthcare non-specialist workers[2].

Thermaiscan Breast Cancer Pre-Screening solution was 1 of 14 winners in India-Sweden Innovation Challenge[3] at the end of November 2020 during Covid-19 pandemic. Thermaiscan has since 2021 received tremendous support from the India-Sweden Healthcare Innovation Centre. The support includes a partnership between India’s premier healthcare institutions AIIMS Delhi, AIIMS Jodhpur and Business Sweden, closely guided by the Ministry of Health (including ICMR) in Sweden and India, along with Knowledge Partner AstraZeneca as well as Technology Partner NASSCOM[4].

Thermaiscan Pre-Screening of breast cancer. Portable, easy to use and no need for a specialist.

There is a significant increase in the number of cancer patients in India from 1990 to 2016, as per the report published in the Lancet. The crude cancer incidence rate in India has increased by 28.2% owing to various environmental and genetic factors. Breast cancer accounts for 8.2% of total cancer cases in India. Therefore, the government of India has started looking for AI-based diagnosing approaches for the diagnosis of various types of cancer[5].

In India, about 1 in 28 women are expected to develop breast cancer during their lifetime[6]. It is crucial to have portable, simple and affordable screening solutions both for non-specialists in healthcare and for the end users – the millions of women in India who don’t have access to screenings or specialists. In India, the cost of a Mammography ranges from INR 800 and could go up to INR 3000[7]. More than 25% of India’s population has a monthly income of less than INR 1,000[8], and this price for many women is not affordable. This means several women at risk in India are unable to understand the early signs of breast cancer.

This is MAMTA-HIMC

MAMTA-HIMC, was founded by a well-known practicing pediatrician, Dr Sunil Mehra, by designing interventions for the underprivileged communities in the Tigri slums of south Delhi in 1990. Since then the organization has developed initiatives focused on strengthening the health system; and developing partnerships and networks that promote healthcare of marginalized people.

During these years, MAMTA-HIMC has promoted strategic solutions, policies and programming, research and global learning in the fields of Maternal Newborn Child Health and Nutrition, Young People’s Sexual Reproductive Health and Rights, HIV, TB and Non-Communicable Diseases, with a special focus on promoting rights, gender equality and equity.

In the normal course, MAMTA-HIMC mobilizes the community, build the capacities of health systems, evidence generation on various determinants of healthcare, network with like-minded institutions/civil societies and nudge the government on evidence-based programming.

The focus area for MAMTA includes maternal, newborn child health and nutrition, pre-pregnancy, ante-natal care and post-partum and sexual reproductive health. It further works towards young people’s sexual reproductive health and rights, and its key determinants such as adverse gender norms, early/child marriage, and nutrition. In addition, the organization promotes awareness on the prevention of communicable diseases and non-communicable diseases along with a comprehensive healthcare support system for early detection and referral services for HIV, TB, diabetes, hypertension, cardiovascular disease, and cancer among marginalized communities.

Read more at mamta-himc.in

Thermal technology can transform the healthcare

Thermal technology is rapidly evolving and sensors are becoming smaller, more sensitive and better. The healthcare system can take advantage of this evolution and Thermaiscan is part of building this new future.

In May 2022, Anna Riby, Regional Director at the Swedish organization Swecare arranged a meeting between the founder and Executive Director of MAMTA-HIMC, Dr Sunil Mehra, and the Thermaiscan’s co-founder and COO, Arby Leonian. The meeting went well, and since then relationships have been established and a common understanding has been reached to sign LOI. 

Once the Thermaiscan Breast Cancer Pre-Screening has passed clinical trials and a medical paper has been published, MAMTA-HIMC will start a community-based evaluation of the product. Through its extensive reach across 20 states in India, MAMTA-HIMC will support its uptake in public and private health facilities.

This is Swecare

Swecare is a unique non-profit platform where academia, public and private sector join forces toward enhanced export and internationalization of Swedish health care and life science. Swecare was founded in 1978 by the Swedish government and the healthcare industry together as a semi-governmental non-profit organization.

Today, Swecare has more than 100 Swedish companies and organizations in its network. The members represent the entire health care spectrum – from the small startup company to university hospitals, regions, and global corporations, working with everything from biotech to medical technology, pharmaceuticals, and health care services.Swecare’s work is based on the triple helix model where academia, public sector, and private sector jointly address health care challenges. Joining forces and addressing problems from multiple angles in turn increases collaboration and international competitiveness of Swedish health care.

Read more at swecare.se


Sources

[1] https://www.komen.org/breast-cancer/facts-statistics/breast-cancer-statistics/survival-rates/

[2] https://www.astrazeneca.com/country-sites/singapore/press-releases/astrazeneca-singapore-signs-mou-with-tech-partners-on-innovation-projects.html

[3] https://www.ciotechoutlook.com/news/indiasweden-healthcare-innovation-centre-awards-fourteen-healthcare-startups-in-prestigious-innovation-challenge-nid-6362-cid-19.html

[4] https://www.coe-iot.com/blog/thermaiscan-technology-reimagining-the-future-of-screening-with-ai-and-thermal-technology/

[5] https://www.indiascienceandtechnology.gov.in/sites/default/files/cancer%20story.pdf

[6] Breast Cancer in India, The Times of India, June 30, 2020

https://timesofindia.indiatimes.com/blogs/poverty-of-ambition/breast-cancer-in-india/

[7] https://www.medifee.com/tests/mammography-cost/

[8] 25% of India’s population still poor, says Niti Aayog, Hindustan Times, Nov 28, 2021

https://www.hindustantimes.com/india-news/25-of-india-s-population-still-poor-says-niti-aayog-101638041167194.html